Table 1.
Summary of the results of photodynamic detection using 5-aminolevulinic acid.
| Malignant Tumors (103/116) 1 | Benign Tumors (8/14) | Non-Neoplastic Lesions (6/14) | ||
|---|---|---|---|---|
| Carcinomas (57/64) | Sarcomas (32/36) | Other Tumors (14/16) | ||
| Mammary gland tumor (29/32) | Osteosarcoma (7/8) | Mast cell tumor (11/13) | Skin appendage tumor (2/3) | Lymphadenopathy (1/4) |
| Transitional cell carcinoma (5/5) | Leiomyosarcoma (5/5) | Lymphoma (3/3) | Lipoma (0/2) | Nodular hyperplasia (2/2) |
| Adenocarcinoma (5/5) | Melanoma (5/5) | Sebaceous gland tumor (1/1) | Adenomatous hyperplasia (1/1) | |
| Sertoli cell tumor (2/4) | Liposarcoma (5/5) | Histiocytoma (1/1) | Cystitis (1/2) | |
| Thyroid carcinoma (3/3) | Hemangiosarcoma (2/5) | Plasmacytoma (1/1) | Panniculitis (1/2) | |
| Schwanoma (2/3) | Hemangiopericytoma (3/3) | Trichoepithelioma (1/1) | Granuloma (0/1) | |
| Hepatocellular carcinoma (3/3) | Sarcoma (1/1) | Transitional cell papilloma (1/1) | Rhinitis (0/1) | |
| Squamous cell carcinoma (3/3) | Chondrosarcoma (1/1) | Granular cell tumor (1/1) | Testitis (0/1) | |
| Perianal gland tumor (1/1) | Fibrosarcoma (1/1) | Fibroma (0/1) | ||
| Salivary gland carcinoma (1/1) | Gastrointestinal stromal tumor (1/1) | Leiomyoma (0/1) | ||
| Malignant trichoepithelioma (1/1) | Histiocytic sarcoma (1/1) | Myelolipoma (0/1) | ||
| Sebaceous gland carcinoma (1/1) | ||||
| Glioblastoma (1/1) | ||||
| Astrocytoma (0/1) | ||||
1 Numbers in parentheses: Number of positive subjects/number of positive and negative subjects.